ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

St Jude Defibrillator Lead Performed Worse Than Competitor Lead -Study

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- St. Jude Medical Inc.'s (STJ) Riata defibrillator leads performed significantly worse than Medtronic Inc.'s (MDT) Quattro leads, according to results from a multicenter study presented at a medical meeting Thursday. St. Jude stopped selling the Riata leads in 2010, but about 79,000 are still implanted in patients in the U.S. St. Jude said last year it was recalling them due to a tendency for the metal wires to wear through their silicone covering. Data in the study, presented at the Heart Rhythm Society meeting in Boston, was collected retrospectively from seven centers. Researchers evaluated the leads for all causes of failure, including cases where cables wore through their coating and electrical malfunctions. Riata, but not Riata ST, leads performed significantly worse than Quattro, according to the study. But follow-up for Riata ST was shorter than it was for Riata. The study also found that nearly a third of leads with exposed cables were malfunctioning. St. Jude said in a statement that the data is consistent with the company's findings that significant design changes implemented in the Riata ST leads resulted in improved performance compared to the Riata leads. In March, a study authored by Robert G. Hauser, a Minnesota cardiologist, tied a malfunction in Riata to at least 20 deaths. Dr. Hauser said the deaths alleged from Riata malfunctions were about nine times greater than Quattro. Last month, St. Jude said it was seeking a retraction of the study, published in the Heart Rhythm Journal. The company says Dr. Hauser undercounted deaths linked to Quattro. St. Jude shares were up 2.3% to $40.12 in recent trading. The stock is down 24% in the last year. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
07/27/201615:20:42Statement of Changes in Beneficial Ownership (4)
07/27/201615:15:13REALITY Trial Enrolls First Patient in Study Evaluating Medtronic...
07/25/201601:00:13Medtronic Unveils VariLoc Variable Angle Locking Technology for...
07/20/201610:00:14Medtronic Receives First-Ever FDA Clearance for Cement-Augmented...
07/19/201613:58:28Statement of Changes in Beneficial Ownership (4)
07/19/201609:00:33Medtronic Expands Continuous Glucose Monitoring (CGM) Solutions...
07/18/201609:00:34Medtronic Receives FDA Approval for Two-Level Prestige LP(TM...
07/15/201617:03:00Proxy Statement - Notice of Shareholders Meeting (preliminary...
07/15/201611:00:19Medtronic Foundation Calls for Applications for 2016 Bakken Invitation...
07/15/201610:00:08Medtronic Launches Revamped Minimally Invasive Spine Fusion Procedures
07/14/201616:42:16Statement of Changes in Beneficial Ownership (4)
07/14/201616:31:08Statement of Changes in Beneficial Ownership (4)
07/13/201609:00:20Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm...
07/13/201609:00:00Sales of Medical Wearable Devices Jump in 2016
07/11/201609:00:17FDA Clears Expanded Indications for Medtronic NuVent(TM) EM Sinus...
07/08/201609:23:48Statement of Changes in Beneficial Ownership (4)
07/06/201616:34:03Statement of Changes in Beneficial Ownership (4)
07/01/201617:31:00Medtronic Files 8K - Changes Executive Management
07/01/201617:02:31Current Report Filing (8-k)
06/30/201618:21:00NuVasive Agrees to Pay $45 Million to Settle Patent Dispute With...

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad